Evidence map›Paper›PMID 41428141›Full record

ArticleEJNMMI research2025

Chaofeng Liu, Zhongyuan Guo, Yiwei Shi, Zhifang Wu, Zhenyu Xiang, Tian Yao, Gang Liang, Zhixing Qin, Ruonan Wang, Li Li and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Chaofeng LiuDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, 56 Jiefang South Road, Taiyuan, 030001, Shanxi, China.
Zhongyuan GuoSchool of Forensic Medicine, Shanxi Medical University, Jinzhong, Shanxi, China.
Yiwei ShiNational Health Commission Key Laboratory of Pneumoconiosis; Department of Pulmonary and Critical Care Medicine, Ministry of Education Key Laboratory of Coal Environmental Pathogenicity and Prevention, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Zhifang WuDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, 56 Jiefang South Road, Taiyuan, 030001, Shanxi, China.
Zhenyu XiangCollaborative Innovation Center for Molecular Imaging of Precision Medicine, Shanxi Medical University, Taiyuan, Shanxi, China.
Tian YaoDepartment of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, China.
Gang LiangDepartment of Pathology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Zhixing QinDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, 56 Jiefang South Road, Taiyuan, 030001, Shanxi, China.
Ruonan WangDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, 56 Jiefang South Road, Taiyuan, 030001, Shanxi, China.
Li LiDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, 56 Jiefang South Road, Taiyuan, 030001, Shanxi, China.
Min GuoLaboratory of Animal Center, Shanxi Key Laboratory of Experimental Animal Science and Animal Model of Human Disease, Shanxi Medical University, Jinzhong, Shanxi, China.
Hailong WangSchool of Basic Medicine, Basic Medical Science Center, Shanxi Medical University, Jinzhong, Shanxi, China.
Min PangNational Health Commission Key Laboratory of Pneumoconiosis; Department of Pulmonary and Critical Care Medicine, Ministry of Education Key Laboratory of Coal Environmental Pathogenicity and Prevention, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Sijin LiDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, 56 Jiefang South Road, Taiyuan, 030001, Shanxi, China. lisjnm123@163.com.ORCID http://orcid.org/0000-0003-0361-1248

Funding

the Central Guidance for Regional Science and Technology Development Projects YDZJSX2024B010the National Natural Science Foundation U22A6008
6 · The paper itself

Abstract

backgroundPneumoconiosis, characterized by dust-induced pulmonary fibrosis, lacks reliable methods to assess fibrotic activity. This study aimed to monitor fibroblast activation and identify activated pulmonary fibrosis for early diagnosis and anti-fibrotic therapy response by

methodsA single-center prospective clinical study was conducted on 6 pneumoconiosis patients and 4 healthy control individuals. The uptake of

resultsIn our preliminary cohort, compared to the controls, the

conclusions

Indexed as

FAPIPET/CTPneumoconiosisPulmonary fibrosis

Identifiers

PMID41428141
PMCPMC12748494

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.